C M Bidwell & Associates LTD Dexcom Inc Transaction History

C M Bidwell & Associates LTD

  • $162 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$110.31 - $140.45 $772 - $983
-7 Reduced 0.24%
2,946 $334,000
Q1 2024

May 13, 2024
BUY
$114.22 - $140.1 $131,238 - $160,974
1,149 Added 63.69%
2,953 $409,000
Q3 2023

Nov 13, 2023
BUY
$86.06 - $137.93 $155,252 - $248,825
1,804 New
1,804 $168,000
Q2 2019

Aug 07, 2019
SELL
$27.84 - $38.92 $84,912 - $118,706
-3,050 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $74,525 - $101,367
2,655 Added 672.15%
3,050 $363,000
Q4 2017

Feb 02, 2018
BUY
$11.12 - $15.38 $4,392 - $6,075
395
395 $23,000

Others Institutions Holding DXCM

# of Institutions
1,024
Shares Held
352M
Call Options Held
5.51M
Put Options Held
5.61M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email